Search results
...Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-...
Digital Journal· 1 day agoThis current...
Earnings call: Fate Therapeutics reports on clinical progress and finances
Investing.com· 1 day agoThe company's FT819 CAR T-cell therapy showed promise for B-cell-mediated autoimmune diseases, with...
Remarkable cancer breakthrough shows woman's brain tumor almost disappear in just five days
UNILAD· 1 day agoA team of researchers have revealed the 'dramatic responses' three cancer patients had to a new type...
Immune Cells: A Hidden Trigger for Anxiety, Depression, and Alzheimer’s Disease
SciTechDaily· 5 days agoResearch indicates that regulatory T cells (Tregs) might stabilize mood and prevent depression, with...
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 13 hours agoImage source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q1 2024 Earnings Call May 13,...
Acepodia reports preliminary results from ACE1831 Phase I trial
Clinical Trials Arena via Yahoo Finance· 5 days agoClinical-stage biotechnology company Acepodia has reported preliminary results from the Phase I...
Strengthening CAR-T Therapy to Work Against Solid Tumors
CW39 NewsFix· 6 days agoThe promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer ...
Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccine
Medical Xpress· 5 days agoThe study, published in Nature Communications, found that pairing a personalized dendritic cell...
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...
Nature· 5 days agoSingle-cell RNA-seq of primary AML samples and CD4+ T cells before and after their interaction uncovered transcriptional programs that correlate with AML sensitivity or resistance to CD4+ < ...
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoFate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript May 11, 2024 Fate...